SPF
PFE icon

South Plains Financial’s Pfizer PFE Stock Holding History

South Plains Financial’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$400K Sell
14,247
-552
-4% -$14.7K 0.23% 99
2025
Q4 		$368K Sell
14,799
-50
-0.3% -$1.26K 0.22% 100
2025
Q3 		$378K Hold
14,849
– – 0.24% 97
2025
Q2 		$360K Hold
14,849
– – 0.25% 94
2025
Q1 		$376K Sell
14,849
-1,529
-9% -$40K 0.29% 90
2024
Q4 		$434K Buy
+16,378
New +$444K 0.33% 77

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

South Plains Financial's PFE Position: Q1 2026 in Review

South Plains Financial reduced its Pfizer (PFE) stake by 3.7% in Q1 2026, selling an estimated $14.7K and leaving 14,247 shares worth $400K. The position accounts for 0.23% of the portfolio, ranked #99.

South Plains Financial first reported a position in PFE in Q4 2024 and has held it in 6 quarters since. The position peaked at $434K in Q4 2024. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • South Plains Financial held 14,247 shares of Pfizer worth $400K as of Q1 2026.
  • South Plains Financial sold 552 Pfizer shares in Q1 2026, an estimated $14.7K.
  • Pfizer made up 0.23% of South Plains Financial's portfolio in Q1 2026, its #99 holding.
  • South Plains Financial first reported a position in Pfizer in Q4 2024 and has held it in 6 quarters since.
  • South Plains Financial's Pfizer position peaked at $434K in Q4 2024.
  • 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on South Plains Financial's 13F filing for Q1 2026, filed 13 May 2026.